Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid‐19 patients
Mario Rodríguez(Hospital Universitario 12 De Octubre), Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Nerea Castro Quismondo(Hospital Universitario 12 De Octubre), Daniel Gil-Alós(University of California, San Francisco), Rosa Ayala(Hospital Universitario 12 De Octubre), D. Zafra Torres(Hospital Universitario 12 De Octubre)
Cited by 30
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523